Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men

NCT07402759 is registered in ClinicalTrials.gov with South Valley University as lead sponsor.

NCT NCT07402759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07402759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men
Lead sponsor
South Valley University
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 1, 2026
Completion date
August 31, 2026
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male infertility, oligoasthenozoospermia